SCHEMBL8565733

SCHEMBL8565733

COC(=O)c1ccc(Oc2cccc(O)c2CCCO)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4A11 Q02928 4/20 0.54
CYP4F2 P78329 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
POLB P06746 1/20 0.44
LPAR1 Q92633 1/20 0.43
LPAR5 Q9H1C0 1/20 0.43
MAPT P10636 3/20 0.43
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
RAB9A P51151 2/20 0.43
LMNA P02545 2/20 0.42
CNR1 P21554 2/20 0.42
CNR2 P34972 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
CA12 O43570 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9151181 0.89 CYP4F2 (0.52) CYP4A11CYP4F2L3MBTL1TDP1POLB
SCHEMBL8567607 0.85 MAPT (0.44) L3MBTL1TDP1POLBLPAR1LPAR5
SCHEMBL8561540 0.80 MAPT (0.43) L3MBTL1TDP1POLBLPAR1LPAR5
SCHEMBL8322752 0.78 CYP4A11 (0.55) CYP4A11CYP4F2L3MBTL1LPAR1LPAR5
SCHEMBL5205615 0.78 CA12 (0.49) L3MBTL1TDP1POLBMAPTESR1
SCHEMBL1556958 0.76 MAPT (0.50) CYP4A11CYP4F2L3MBTL1TDP1LPAR1
SCHEMBL11411879 0.75 CA1 (0.62) L3MBTL1TDP1POLBLPAR1LPAR5
SCHEMBL8561742 0.75 CYP4A11 (0.55) CYP4A11CYP4F2POLBMAPTESR1
SCHEMBL8486209 0.73 CYP4A11 (0.52) CYP4A11CYP4F2L3MBTL1POLBLPAR1
SCHEMBL1191950 0.73 TDP1 (0.68) L3MBTL1TDP1LPAR1LPAR5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0544488-B1 Substituted phenyl phenol leukotriene antagonists LILLY CO ELI (US) 1998-03-11 EP disclosed
CN-1035001-C Substituted phenyl phenol leukotriene antagonists LILLY CO ELI (US) 1997-05-28 CN disclosed
WO-1996036347-A1 USE OF LEUKOTRIENE ANTAGONISTS FOR ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1996-11-21 WO disclosed
EP-0743064-A1 Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease ELI LILLY AND COMPANY (US) 1996-11-20 EP disclosed
US-5462954-A Antiinflammatory, antiallergens; treating asthma ELI LILLY AND COMPANY (US) 1995-10-31 US disclosed
EP-0544488-A2 Substituted phenyl phenol leukotriene antagonists ELI LILLY AND COMPANY (US) 1993-06-02 EP disclosed